#USA #financial results #Madison #Accuray #Fiscal 2025

Accuray Incorporated's Financial Results for Fiscal Year 2025

On August 13, 2025, Accuray Incorporated (NASDAQ: ARAY) announced its financial results for the fourth quarter and fiscal year ending June 30, 2025. Despite facing various market challenges, the company reported key growth metrics that highlight a pathway forward.

Key Highlights of the Fourth Quarter

In the fourth quarter, Accuray generated net revenue of $127.5 million, signifying a 5% decline from the previous year. The company's net income stood at $1.1 million, a decrease from $3.4 million last year, indicating a tough but resilient quarter. Adjusted EBITDA fell to $9.4 million, representing a slight reduction from $10.1 million in the prior period.

Despite these figures, the order book-to-bill ratio remained strong at 1.2, demonstrating robust demand for Accuray's offerings. Service revenue slightly increased, reflecting the company's strategic focus on customer service and support, while product revenue faced challenges, decreasing by 11% year-over-year.

Fiscal Year Overview

For the entire fiscal year 2025, Accuray recorded a net revenue of $458.5 million, up 3% from $446.6 million in the prior year. This revenue growth was driven by a 1% increase in product revenue and a 4% growth in service revenue.

The net loss for the fiscal year was $1.6 million, a significant improvement from the $15.5 million loss reported last year. The adjusted EBITDA for the year reached $28.3 million, compared to $19.7 million in 2024, indicating effective cost management and operational efficiency.

Operational Achievements

Suzanne Winter, President and CEO, expressed pride in the company's ability to navigate a challenging environment while achieving revenue growth and expanding service performance. A significant achievement highlighted was the successful refinancing of the company's debt with a strategic partner committed to its long-term success. This maneuver is expected to stabilize Accuray's financial foundation and facilitate continued growth.

Furthermore, the gross profit margin improved slightly, reaching 32.1% of net revenue for the fiscal year, compared to 32.0% the previous year, indicating effective management of production and operational costs.

Looking Ahead: Fiscal Year 2026 Guidance

Accuray has introduced guidance for fiscal year 2026, forecasting total net revenue between $471 million to $485 million and an adjusted EBITDA anticipated between $31 million to $35 million. This optimistic outlook reflects the company's confidence in its core strategies and ongoing product innovation.

The company's management is anticipating growth in revenue driven by an expanding product portfolio and increasing customer adoption in the market. They expect that ongoing improvements in service delivery will further strengthen their competitive positioning.

Conclusion

As Accuray positions itself for future growth, stakeholders should monitor how the company will leverage its innovations in radiation therapy and its operational efficiencies to overcome market challenges. The forthcoming fiscal year promises to be critical for Accuray as it aims to solidify its market leadership in the oncology sector and enhance patient care experiences worldwide.

For more information, Accuray will be hosting a conference call to discuss these financial results and answer queries from stakeholders.